Skip to content

Insider · CIK 0002141639

David I Malek

director

Files at BRVE (Braveheart Bio, Inc.). First filing Aug 7, 2026, latest Aug 7, 2026.

In brief

David I Malek files SEC Form 4 as director at BRVE (Braveheart Bio, Inc.). Since Aug 7, 2026, David I Malek has reported 1 open-market buy worth $75k and 0 open-market sells worth $0, the latest filed on Aug 7, 2026.

A track record needs three past buys with six months of prices behind them; David I Malek has 0, so none is measured yet.

The newest scored trade: bought $75k of BRVE on Aug 7, 2026, filed Aug 7, 2026, scored 33 (weak). In the last 12 months: 1 buy worth $75k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$75k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BRVE: Braveheart Bio, Inc.

BRVEOct 12, 2026 · close 20.36

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
33Weak
BRVEbuy 10
Braveheart Bio, Inc.
$75k
4,166 shares
+1%-

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 7, 2026BRVE
Braveheart Bio, Inc.
POpen-market purchase
Common Stock
+4,166$18.00$75k533,845Aug 7, 2026
Aug 5, 2026BRVE
Braveheart Bio, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+30,000$0.00$030,000Aug 7, 2026

Questions about David I Malek

Answered from the filings on this page, as of the latest one.

Is David I Malek buying or selling?

In the last 12 months David I Malek reported 1 open-market buy worth $75k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $75k of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.

How did David I Malek's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David I Malek has 0.

Where does David I Malek file Form 4?

David I Malek has filed Form 4 at BRVE (Braveheart Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

David I Malek: insider trades and track record | InsiderTell